PTC Therapeutics, Inc. (PTCT)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 34.03 |
| Open | 33.94 |
| Bid | 33.05 x 200 |
| Ask | 33.14 x 400 |
| Day's range | 32.88 - 33.94 |
| 52-week range | 17.53 - 59.84 |
| Volume | |
| Avg. volume | 868,012 |
| Market cap | 2.538B |
| Beta (5Y monthly) | 0.63 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Investor's Business Daily
PTC Therapeutics Stock Sees IBD RS Rating Climb To 72
PTC Therapeutics shows improving price performance, earning an upgrade to its IBD Relative Strength Rating
- Insider Monkey
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q1 2024 Earnings Call Transcript
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q1 2024 Earnings Call Transcript April 25, 2024 PTC Therapeutics, Inc. beats earnings expectations. Reported EPS is $-1.2, expectations were $-1.31. PTC Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank […]
- Simply Wall St.
Industry Analysts Just Made A Captivating Upgrade To Their PTC Therapeutics, Inc. (NASDAQ:PTCT) Revenue Forecasts
PTC Therapeutics, Inc. ( NASDAQ:PTCT ) shareholders will have a reason to smile today, with the analysts making...
© 2024 Yahoo. All rights reserved.